TOP2B and colorectal carcinoma: Zhang et al. discussed the effect of Girdin silencing on colorectal cancer (CRC) cell sensitivity to oxaliplatin-based chemotherapy and the possible mechanism, and they discovered that Girdin silencing improved the sensitivity of GC cells to oxaliplatin by down-regulating TOP2B (Zhang et al. 2014).